New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Access the report

›ETF Issuers›Tidal›PBPH

PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

Passive ETF Equity

Not rated

The PBPH Exchange Traded Fund (ETF) is provided by Tidal. It is built to track an index: BITA Global Pharma and Biotech Select Index. The PBPH ETF provides physical exposure, so by buying it you actually own parts of all the 52 underlying holdings. This share class generates a stream of income by distributing dividends.

$31.35

+$0.59 (+1.92%) yesterday

1:30 PM 10/30/26 Closed

1D price range

$31.26$31.64

52W price range

$24.18$31.64

YTD Perf.

+24.11%

YTD Flows

Annualized volatility

Fund AuM

€1.07B

Share class AuM

€1.07B

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US88635A2042

TER

0.13%

Inception date

11/24/2025

Issuer

Tidal

Benchmark

BITA Global Pharma and Biotech Select Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
WELZ Amundi S&P World Health Care Screened UCITS ETF	+1.61%
WDHE Invesco S&P World Health Care ESG UCITS ETF	+4.65%
DRUG BetaShares Global Healthcare ETF - Currency Hedged	+0.56%
IXJ iShares Global Healthcare ETF	+3.02%
XDWH Xtrackers MSCI World Health Care UCITS ETF	+1.37%
IXJ iShares Global Healthcare ETF (AU)	+0.87%
WHEA State Street SPDR MSCI World Health Care UCITS ETF	+3.15%
WHCA iShares MSCI World Health Care Sector Advanced UCITS ETF	+2.85%
XHC iShares Global Healthcare Index ETF	+2.93%
CHCL.B CI Global Healthcare Leaders Index ETF	+3.04%
ZGHC BMO Global Health Care Fund Active ETF Series	+3.34%
JDOC JPMorgan Healthcare Leaders ETF	+3.27%
PPH VanEck Pharmaceutical ETF	+3.80%
TDOC.U TD Global Healthcare Leaders Index ETF	+1.78%
XDG3 Xtrackers MSCI Global SDG 3 Good Health UCITS ETF	+1.87%

API

PerformanceDec 31, 2025 - Oct 30, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 09/30/26

Healthcare

99.62%

Unavailable

0.38%

Latest PBPH news

No content available for this fund

FAQ about PBPH

PBPH is a passively managed ETF that invests in the DM Large & Mid Cap segment.

PBPH tracks the BITA Global Pharma and Biotech Select GRT Index - USD, through a full replication replication method.

PBPH carries a total expense ratio (TER) of 0.13%.

PBPH was introduced to the market on November 24, 2025.

Portfolio Building Block World Pharma and Biotech Index ETF, PBPH, is provided by Tidal. Learn more about Tidal here.

PBPH oversees €1.07B in assets as of October 30, 2026.

PBPH follows a distributing dividend policy, meaning it pays out income to investors.

As of September 30, 2026, PBPH has significant geographic allocations in USA, Switzerland and United Kingdom.

As of September 30, 2026, PBPH focuses largely on Healthcare.

As of September 30, 2026, PBPH holds 52 positions in its portfolio, with 75.51% of assets concentrated in its top 15 holdings.

As of September 30, 2026, PBPH top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

The base currency of PBPH is USD.

Top 10 holdings

Data as of 09/30/26

Eli Lilly & Co.

15.52%

Johnson & Johnson

10.01%

AbbVie, Inc.

7.23%

Merck & Co., Inc.

5.72%

Roche Holding AG

4.61%

AstraZeneca PLC

4.59%

Amgen, Inc.

4.37%

Novartis AG

4.09%

Gilead Sciences, Inc.

3.98%

Pfizer Inc.

3.47%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Portfolio Building Block World Pharma and Biotech Index ETF

FAQ about PBPH

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US